BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer - Marketscreener.com
GTHDelisted Stock | USD 0.94 0.02 2.08% |
Under 62% of Genetron Holdings' investor base is looking to short. The analysis of current outlook of investing in Genetron Holdings suggests that many traders are alarmed regarding Genetron Holdings' prospects. Genetron Holdings' investing sentiment shows overall attitude of investors towards Genetron Holdings.
Genetron |
BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer Marketscreener.com
Read at news.google.com
Genetron Holdings Fundamental Analysis
We analyze Genetron Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genetron Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genetron Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Genetron Holdings is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Genetron Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genetron Holdings stock to make a market-neutral strategy. Peer analysis of Genetron Holdings could also be used in its relative valuation, which is a method of valuing Genetron Holdings by comparing valuation metrics with similar companies.
Peers
Genetron Holdings Related Equities
SERA | Sera Prognostics | 5.72 | ||||
FONR | Fonar | 1.45 | ||||
XGN | Exagen | 0.61 | ||||
NOTV | Inotiv | 0.00 | ||||
BDSX | Biodesix | 0.67 | ||||
SHC | Sotera Health | 0.74 | ||||
ACRS | Aclaris Therapeutics | 1.60 | ||||
MDXH | MDxHealth | 2.27 | ||||
PRE | Prenetics Global | 5.64 | ||||
CSTL | Castle Biosciences | 15.10 | ||||
DRIO | DarioHealth Corp | 41.18 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Commodity Directory Find actively traded commodities issued by global exchanges |